QQQ $ 480.15 $ -1.01 (-0.21 %)
DIA $ 408.54 $ -0.55 (-0.13 %)
SPY $ 558.65 $ -0.91 (-0.16 %)
TLT $ 98.68 $ 0.78 (0.8 %)
GLD $ 232.46 $ 0.85 (0.37 %)
$ 25.2
-- x --
-- x --
-- - --
$ 20.50 - $ 28.00
1,500
na
na
$ -18.97
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Evotec is entitled to receive double-digit royalties of net sales as well as milestones based on commercial success and further...

 apple-loses-appeal-over-4g-patent-infringement-in-london-court-ai-can-drive-tsmcs-revenue-rebound-alibaba-conducts-strategic-review-of-youku-and-tudou-amidst-rivalry-todays-top-stories

Reuters

 evotec-secures-us-government-contract-for-orthopoxvirus-antibody

The U.S.

Core News & Articles

Evotec and Bristol Myers Squibb entered their strategic protein degradation partnership in 2018 and expanded it in May of 202...

Core News & Articles

Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX)(OTC: EVOTF)(NASDAQ: EVO) today announced that the U.S. Department of Defe...

 the-daily-biotech-pulse-fda-decision-on-biogen-alzheimers-drug-due-in-january-fda-reviews-roches-lymphoma-candidate-rare-pediatric-tag-for-kazias-pediatric-brain-cancer-candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

Core News & Articles

Clinical data builds upon body of evidence suggesting EXS-21546 is a highly potent and selective A2AR antagonist with low CNS e...

 why-are-evotec-shares-trading-lower-on-friday

Bayer AG (OTC: BAYRY) has 

Core News & Articles

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that the Company has en...

Core News & Articles

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that the Company has ex...

 germany-based-evotec-sets-terms-for-576m-us-ipo

German biotech Evotec SE (OTC: EVTCY) plans to raise $576 million by offering 22 million ADSs at $26.16. At the proposed pric...

Core News & Articles

Kazia Therapeutics Limited (NASDAQ: KZIA) is pleased to announce that it has entered into a worldwide exclusive licensing agre...

Core News & Articles

Chinook Therapeutics Inc (NASDAQ: KDNY) and Evotec SE (OTCMKTS: EVTCY) have 

Core News & Articles

Centogene N.V.

Core News & Articles

Evotec SE (OTC: EVOTF) and Novo Nordisk (NYSE: NVO) today announced a strategic collaboration on the discovery and development ...

 the-daily-biotech-pulse-fda-nod-for-glaxosmithkline-hologic-to-launch-coronavirus-test-amarins-strong-q1

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION